TimothySilleckBaileyMD

Endocrinology • Escondido, CA

Diabetes, Lipid Metabolism, Thyroid

Physician

Join to view full profile

Dr. Bailey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Bailey's full profile

Already have an account?

Office
625 Citracado Pkwy
Ste 108
Escondido, CA 92025
Phone+1 760-743-1431

Fax+1 760-743-6455
Is this information wrong?

Education & Training

SUNY Downstate Health Sciences UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1987 - 1990
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1984 - 1987
Icahn School of Medicine at Mount SinaiClass of 1984

Certifications & Licensure

CA State Medical License 1987 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification eClinicalWorks EHR, eClinicalWorks LLC, 2013
Fellow (FACE) American Association of Clinical Endocrinology

Clinical Trials

Overnight Closed Loop Study in U.S. Start of enrollment: 2013 Jun 01
Completed
Not Applicable
Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data Start of enrollment: 2013 Nov 26
Completed
Not Applicable
In Clinic Evaluation of the PLGM Feature Start of enrollment: 2014 Oct 01
Completed
Not Applicable
Hybrid Closed Loop Pivotal Trial in Type 1 Diabetes Start of enrollment: 2015 Jun 01
Completed
Not Applicable
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM Start of enrollment: 2015 Sep 01
Completed
Phase 2
Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients Start of enrollment: 2015 Aug 01
Completed
Not Applicable
An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2015 Oct 20
Completed
Phase 3
Safety Evaluation of the Hybrid Closed Loop (HCL) System in Pediatric Subjects With Type 1 Diabetes Start of enrollment: 2016 Apr 18
Completed
Not Applicable
Assessment of Mealtime Bolus Insulin Behavior Start of enrollment: 2017 Dec 11
Completed
Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics Start of enrollment: 2020 Jul 15
Completed
Not Applicable
FreeStyle Libre Continuous Glucose Monitoring System Accuracy Study Start of enrollment: 2020 Jul 10
Completed
Clinical Investigation of K'Watch - Lab & Home Study Start of enrollment: 2021 Nov 15
Recruiting
Roles: Contact
Enhance Study: Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features Start of enrollment: 2021 Oct 20
Recruiting
Not Applicable
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Opportunities to overcome underutilization of enhanced insulin delivery technologies in people with type 2 diabetes: a narrative review.
Davida F Kruger, Diana Isaacs, Lucille Hughes, Eden Miller, Timothy S Bailey> ;Postgraduate Medicine. 2024 Mar 21
2 citations
Increased Time in Range with Ultra Rapid Lispro Treatment in Participants with Type 2 Diabetes: PRONTO-Time in Range.
Timothy S Bailey, Bruce W Bode, Qianqian Wang, Alastair W Knights, Annette M Chang> ;Diabetes Therapy. 2023 May 1
4 citations
Clinical outcomes in high-hypoglycaemia-risk patients with type 2 diabetes switching to insulin glargine 300 U/mL versus a first-generation basal insulin analogue in t...
Sean D. Sullivan, Nick Freemantle, Rishab Gupta, Jasmanda Wu, Charlie Nicholls, Jukka Westerbacka, Timothy S. Bailey> ;Endocrinology, Diabetes & Metabolism. 2021 Nov 22
17 citations
Dasiglucagon, a next-generation ready-to-use glucagon analog, for treatment of severe hypoglycemia in children and adolescents with type 1 diabetes: Results of a phase...
Tadej Battelino, Ramin Tehranchi, Timothy S. Bailey, Klemen Dovc, Anita E. Melgaard, Jenine Y Stone, Stephanie Woerner, Thekla von dem Berge, Linda A. DiMeglio, Thomas...> ;Pediatric Diabetes. 2021 Jun 9
5 citations
Improvement in Patient-Reported Outcomes in Adults with Type 1 Diabetes Treated with Sotagliflozin plus Insulin Versus Insulin Alone
Thomas Danne, Vijay N. Joish, Marion Afonso, Phillip Banks, Sangeeta Sawhney, Pablo Lapuerta, Michael J Davies, John B. Buse, Dee Lin, M. Reaney, Sophie Guillonneau, F...> ;Diabetes Technology & Therapeutics. 2021 Jan 1
20 citations
Comparable glycaemic control and hypoglycaemia in adults with type 2 diabetes after initiating insulin glargine 300 units/mL or insulin degludec: The DELIVER Naïve D r...
Sean D. Sullivan, Charlie Nicholls, Rishab Gupta, Arjun A. Menon, Jasmanda Wu, Jukka Westerbacka, Zsolt Bosnyak, Juan P. Frias, Timothy S. Bailey> ;Diabetes, Obesity & Metabolism. 2019 Sep 1
23 citations
Glycaemic goal attainment and hypoglycaemia outcomes in type 2 diabetes patients initiating insulin glargine 300 units/mL or 100 units/mL: Real-world results from the ...
Timothy S. Bailey, Fang L. Zhou, Rishab Gupta, Ronald Preblick, Vineet E. Gupta, Paulos Berhanu, Lawrence Blonde> ;Diabetes, Obesity & Metabolism. 2019 Jul 1
20 citations
Implementation of Basal-Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with an Insulin Pen.
Richard M. Bergenstal, Mark Peyrot, Darlene M. Dreon, Vanita R. Aroda, Timothy S. Bailey, Ronald L. Brazg, Juan P. Frias, Mary L. Johnson, David C. Klonoff, Davida F. ...> ;Diabetes Technology & Therapeutics. 2019 May 7
3 citations
Hypoglycaemia as a function of HbA1c in type 2 diabetes: Insulin glargine 300 U/mL in a patient-level pooled analysis of EDITION 1, 2 and 3.
Riccardo C. Bonadonna, Jean-François Yale, Claire Brulle-Wohlhueter, Emmanuelle Boëlle-Le Corfec, Pratik Choudhary, Timothy S. Bailey> ;Diabetes, Obesity & Metabolism. 2019 Mar 1
14 citations
Day-to-day fasting self-monitored blood glucose variability is associated with risk of hypoglycaemia in insulin-treated patients with type 1 and type 2 diabetes: A pos...
J. Hans DeVries, Timothy S. Bailey, Anuj Bhargava, Gregg Gerety, Janusz Gumprecht, Simon Heller, Wendy Lane, Carol Wysham, Bernard Zinman, Britta A. Bak, Elise Hachman...> ;Diabetes, Obesity & Metabolism. 2019 Mar 1
47 citations
Rates of Hypoglycemia Predicted in Patients with Type 2 Diabetes on Insulin Glargine 300 U/ml Versus First- and Second-Generation Basal Insulin Analogs: The Real-World...
Jeremy Pettus, Ronan Roussel, Fang Liz Zhou, Zsolt Bosnyak, Jukka Westerbacka, Rachele Berria, Javier Jimenez, Björn Eliasson, Irene Hramiak, Timothy S. Bailey, Luigi ...> ;Diabetes Therapy. 2019 Feb 14
129 citations
Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes.
Gregory P. Forlenza, Orit Pinhas-Hamiel, David R Liljenquist, Dorothy I. Shulman, Timothy S. Bailey, Bruce W. Bode, Michael A Wood, Bruce A. Buckingham, Kevin B Kaiser...> ;Diabetes Technology & Therapeutics. 2019 Jan 8
18 citations
In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes.
Michael A Wood, Dorothy I. Shulman, Gregory P. Forlenza, Bruce W. Bode, Orit Pinhas-Hamiel, Bruce A. Buckingham, Kevin B Kaiserman, David R Liljenquist, Timothy S. Bai...> ;Diabetes Technology & Therapeutics. 2018 Oct 25
32 citations
Improved Postprandial Glucose with Inhaled Technosphere Insulin Compared with Insulin Aspart in Patients with Type 1 Diabetes on Multiple Daily Injections: The STAT Study
Halis Kaan Akturk, Janet K. Snell-Bergeon, Amanda Rewers, Leslie J. Klaff, Bruce W. Bode, Anne L. Peters, Timothy S. Bailey, Satish K. Garg> ;Diabetes Technology & Therapeutics. 2018 Sep 26
142 citations
Sotagliflozin in Combination With Optimized Insulin Therapy in Adults With Type 1 Diabetes: The North American inTandem1 Study
John B. Buse, Satish K. Garg, Julio Rosenstock, Timothy S. Bailey, Phillip Banks, Bruce W. Bode, Thomas Danne, Jake A. Kushner, Wendy Lane, Pablo Lapuerta, Darren K. M...> ;Diabetes Care. 2018 Sep 1
19 citations
Accuracy of a Fourth-Generation Continuous Glucose Monitoring System in Children and Adolescents with Type 1 Diabetes.
Robert H. Slover, Jeanie B. Tryggestad, Linda A. DiMeglio, Larry A. Fox, Bruce W. Bode, Timothy S. Bailey, Ronald L. Brazg, Mark P. Christiansen, Jennifer L. Sherr, Ev...> ;Diabetes Technology & Therapeutics. 2018 Sep 1
51 citations
Clinical outcomes in real-world patients with type 2 diabetes switching from first- to second-generation basal insulin analogues: Comparative effectiveness of insulin ...
Sean D. Sullivan, Timothy S. Bailey, Ronan Roussel, Fang Liz Zhou, Zsolt Bosnyak, Ronald Preblick, Jukka Westerbacka, Rishab Gupta, Lawrence Blonde> ;Diabetes, Obesity & Metabolism. 2018 Sep 1
80 citations
Investigation of the Accuracy of 18 Marketed Blood Glucose Monitors.
David C. Klonoff, Joan Lee Parkes, Boris Kovatchev, David Kerr, Wendy C. Bevier, Ronald L. Brazg, Mark P. Christiansen, Timothy S. Bailey, James H. Nichols, Michael Kohn> ;Diabetes Care. 2018 May 31
57 citations
Real-world evidence concerning clinical and economic outcomes of switching to insulin glargine 300 units/mL vs other basal insulins in patients with type 2 diabetes us...
Fang Liz Zhou, Fen Ye, Paulos Berhanu, Vineet E. Gupta, Rishab Gupta, Jennifer Sung, Jukka Westerbacka, Timothy S. Bailey, Lawrence Blonde> ;Diabetes, Obesity & Metabolism. 2018 May 1
6 citations
Strategies for implementing effective mealtime insulin therapy in type 2 diabetes.
Mark Peyrot, Timothy S. Bailey, Belinda P. Childs, Gérard Reach> ;Current Medical Research and Opinion. 2018 Mar 12
11 citations
Improving postprandial hyperglycemia in patients with type 2 diabetes already on basal insulin therapy: Review of current strategies.
Guillermo E. Umpierrez, Timothy S. Bailey, Danielle Carcia, Charles Shaefer, Neil Skolnik> ;Journal of Diabetes. 2018 Feb 1
17 citations
Review of a commercially available hybrid closed-loop insulin-delivery system in the treatment of Type 1 diabetes
Jenine Y Stone, Nalani Haviland, Timothy S. Bailey> ;Therapeutic Delivery. 2018 Feb 1
78 citations
A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II.
Mark P. Christiansen, Leslie J. Klaff, Ronald L. Brazg, Anna R Chang, Carol J. Levy, David K. Lam, Douglas S Denham, George Atiee, Bruce W. Bode, Steven J Walters, Lyn...> ;Diabetes Technology & Therapeutics. 2018 Jan 30
16 citations
The Effect of Prior Continuous Glucose Monitoring Use on Glycemic Outcomes in the Pivotal Trial of the MiniMed™ 670G Hybrid Closed-Loop System.
Toni L. Cordero, Satish K. Garg, Ronald L. Brazg, Timothy S. Bailey, John H. Shin, Scott W. Lee, Francine R. Kaufman> ;Diabetes Technology & Therapeutics. 2017 Dec 1
74 citations
Morning administration of 0.4 U/kg/day insulin glargine 300 U/mL provides less fluctuating 24-hour pharmacodynamics and more even pharmacokinetic profiles compared wit...
Timothy S. Bailey, Jeremy Pettus, Ronan Roussel, W. Schmider, M. Maroccia, N. Nassr, O. Klein, Geremia B. Bolli, R. Dahmen> ;Diabetes & Metabolism. 2017 Nov 16
Join now to see all

Press Mentions

Senseonics Announces First Paediatric Insertion for Eversense in TrialApril 19th, 2023
FDA Clears Medtronic's Smartphone-Connected CGM for MDI UsersMarch 12th, 2018
New 'Smart' CGM System Provides Predictive Alerts to Patients with DiabetesMarch 12th, 2018
Join now to see all